Who Paid My Doc
Tv50717-Cns-40223
Research payments
$2,139,081
Through program year 2025, $2,139,081 in research payments was reported against Tv50717-Cns-40223, across 3,370 payments, paid by Teva Pharmaceuticals USA, Inc..
- Paid by
- Teva Pharmaceuticals USA, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $757,387 | 1,604 |
| 2024 | Research | $1,014,540 | 1,534 |
| 2023 | Research | $357,806 | 230 |
| 2022 | Research | $9,348 | 2 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Leonardo Vando New York, NY Named on 190 payments
- Nancy Gilbert Nashua, NH Named on 122 payments
- Nancy Navarro-Gonzalez Miami, FL Named on 115 payments
- Ashwini Saxena Manchester, NH Named on 115 payments
- Xiaoduo Fan Boston, MA Named on 107 payments
- Vithyalakshmi Selvaraj Lincoln, NE Named on 106 payments
- Steven MacIna Laguna Beach, CA Named on 100 payments
- Chelsie Monroe Englewood, CO Named on 93 payments
- Sharon Evertson Lauderdale Lakes, FL Named on 91 payments
- Abdelrahman Abdelaziz Akron, PA Named on 90 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.